California Biotechnology, Inc.

Basic Information

2450 Bayshore Parkway
Mountain View, CA, 94043

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. WOUND REPAIR WITH HEPARIN-BINDING EGF-LIKE GROWTH FACTOR

    Amount: $414,744.00

    USING HEPARIN AFFINITY CHROMATOGRAPHY, A NOVEL FIBROBLAST AND VASCULAR SMOOTH MUSCLE CELL MITOGEN HAS BEEN ISOLATED FROM THE CONDITIONED MEDIUM OF THE HUMAN HISTIOCYTIC LYMPHOMA CELL LINE U-937. ANALY ...

    SBIR Phase II 1993 Department of Health and Human Services
  2. STRUCTURE AND FUNCTION OF ALZHEIMER'S DISEASE PROTEASE INHIBITOR

    Amount: $496,634.00

    APPROXIMATELY 5 PERCENT OF THE POPULATION OVER AGE 65 IN THEUNITED STATES SUFFERS FROM ALZHEIMER'S DISEASE (AD). DESPITE ITS PREVALENCE, NO EFFICACIOUS TREATMENTS EXIST. DEFINITIVE DIAGNOSIS IS MADE O ...

    SBIR Phase II 1992 Department of Health and Human Services
  3. INHIBITORS OF ATRIAL NATRIURETIC PEPTIDE CLEARANCE

    Amount: $467,104.00

    THE ATRIAL NATRIURETIC PEPTIDE (ANP) HORMONAL SYSTEM, WHICH HAS AN IMPORTANT BIOLOGICAL ROLE IN FLUID AND ELECTROLYTE HOMEOSTASIS, REPRESENTS AN IMPORTANT NEW THERAPEUTIC TARGET FOR CARDIOVASCULAR DIS ...

    SBIR Phase II 1991 Department of Health and Human Services
  4. MOLECULAR CLONING OF CDNA ENCODING OXIDIZED LDL RECEPTOR

    Amount: $48,200.00

    THE LONG TERM OBJECTIVE OF THIS RESEARCH IS TO DEVELOP DRUGS TO PREVENT PROGRESSION/FORMATION OF ATHEROSCLEROTIC LESIONS IN HUMANS. LIPID DEPOSITION IN THE ARTERIAL WALL HAS BEEN SHOWN IN ANIMAL MODEL ...

    SBIR Phase I 1991 Department of Health and Human Services
  5. ISOLATION OF INSULIN RECEPTOR PHOSPHATASES

    Amount: $50,000.00

    THE ULTIMATE OBJECTIVE OF THIS RESEARCH IS TO DEVELOP A NOVEL TREATMENT FOR DIABETES BASED ON THE ENHANCEMENT OF INSULIN ACTION THROUGH THE INHIBITION OF AN INSULIN RECEPTOR-SPECIFIC PHOSPHOTYROSINE P ...

    SBIR Phase I 1991 Department of Health and Human Services
  6. RECOMBINANT CNTF FOR TREATMENT OF NEUROPATHIES

    Amount: $50,000.00

    CILIARY NEUROTROPHIC FACTOR (CNTF) IS A POTENT POLYPEPTIDE HORMONE WHOSE ACTIONS APPEAR TO BE RESTRICTED TO THE NERVOUS SYSTEM. CNTF HAS BEEN OBSERVED TO PROMOTE SURVIVAL, NEUROTRANSMITTER SYNTHESIS A ...

    SBIR Phase I 1991 Department of Health and Human Services
  7. WOUND REPAIR WITH HEPARIN-BINDING EGF-LIKE GROWTH FACTOR

    Amount: $50,000.00

    N/A

    SBIR Phase I 1991 Department of Health and Human Services
  8. ANTIBODIES TO ATRIAL PEPTIDE RECEPTOR

    Amount: $490,968.00

    ATRIAL NATRIURETIC PEPTIDE (ANP) BINDS TO MULTIPLE CELL SURFACE RECEPTORS IN A NUMBER OF DIFFERENT TISSUES, RESULTING IN EFFECTS RELATED TO CARDIOVASCULAR HOMEOSTASIS. THIS RESEARCH INVOLVES THE GENER ...

    SBIR Phase II 1990 Department of Health and Human Services
  9. AN IN VITRO SCREEN FOR ATYPICAL BETA-ADRENERGIC AGONISTS

    Amount: $50,000.00

    THE ULTIMATE GOAL OF THIS RESEARCH IS TO DEVELOP A THERAPY FOR OBESITY BASED UPON THE IDENTIFICATION OF NOVEL BETA-ADRENERGIC AGONISTS THAT ARE SELECTIVE STIMULATORS OF THERMOGENESIS IN HUMANS. ATYPIC ...

    SBIR Phase I 1990 Department of Health and Human Services
  10. A NEW ENDOTHELIAL CELL GROWTH FACTOR FOR WOUND HEALING

    Amount: $50,000.00

    VASCULAR ENDOTHELIAL CELL GROWTH FACTOR (VEGF) IS A POTENT MITOGEN, SECRETED BY BOVINE PITUITARY FOLLICULO-STELLATE CELLS, THAT APPEARS TO BE SPECIFIC FOR VASCULAR ENDOTHELIAL CELLS. THIS SPECIFICITY ...

    SBIR Phase I 1990 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government